Register free for our breaking news email alerts with analysis and cutting edge commentary from our award winning team. Registration only takes a minute.
Please see terms and conditions for restrictions on use of Citywire's Fund Manager database.

This Fund Manager Rating is based on the Citywire Long Only ratings methodology

Citywire Ratings are rewarded for risk adjusted outperformance of benchmarks we select independently More information on how Ratings are calculated

Daniel Mahony

Daniel Mahony

Showing manager performance in Singapore View performance globally

About Daniel Mahony

Daniel Mahony joined Polar Capital in 2007, and manages the Polar Capital Healthcare Opportunities Fund using a growth investment style. Prior to this he was a senior analyst at Morgan Stanley, having also been an associate at ING Barings Furman Selz. Daniel studied at Christ Church College, Oxford and St John's College, Cambridge where he earned a PhD in biochemistry. He is currently based in London and his interests outside of work include rugby, soccer, the cinema and cheese making.

Invests in own strategies

Are you Daniel Mahony?

Citywire Rating: Not Rated

2013

  • SRated AAA in Sep 2013
  • ORated AAA in Oct 2013
  • NRated AAA in Nov 2013
  • DRated AAA in Dec 2013

2014

  • JRated AAA in Jan 2014
  • FRated AAA in Feb 2014
  • MRated AA in Mar 2014
  • ARated AA in Apr 2014
  • MRated AA in May 2014
  • JRated AA in Jun 2014
  • JRated AA in Jul 2014
  • ARated AA in Aug 2014
  • SRated AA in Sep 2014
  • ORated AA in Oct 2014
  • NRated AA in Nov 2014
  • DRated AA in Dec 2014

2015

  • JRated AA in Jan 2015
  • FRated AA in Feb 2015
  • MRated AA in Mar 2015
  • ARated AA in Apr 2015
  • MRated AA in May 2015
  • JRated AA in Jun 2015
  • JRated AA in Jul 2015
  • ARated AA in Aug 2015
  • SRated AA in Sep 2015
  • ORated AA in Oct 2015
  • NRated AA in Nov 2015
  • DRated AA in Dec 2015

2016

  • JRated A in Jan 2016
  • FRated A in Feb 2016
  • MRated A in Mar 2016
  • ARated A in Apr 2016
  • MRated AA in May 2016
  • JRated A in Jun 2016
  • JRated A in Jul 2016
  • ARated A in Aug 2016
  • SRated A in Sep 2016
  • ORated Plus in Oct 2016
  • NRated A in Nov 2016
  • DRated Plus in Dec 2016

2017

  • JRated Plus in Jan 2017
  • FNot rated in Feb 2017
  • MNot rated in Mar 2017
  • ANot rated in Apr 2017
  • MRated Plus in May 2017
  • JNot rated in Jun 2017
  • JNot rated in Jul 2017
  • ANot rated in Aug 2017
  • SNot rated in Sep 2017
  • ONot rated in Oct 2017
  • NNot rated in Nov 2017
  • DNot rated in Dec 2017

2018

  • JNot rated in Jan 2018
  • FNot rated in Feb 2018
  • MNot rated in Mar 2018
  • ANot rated in Apr 2018
  • MNot rated in May 2018

Performance

Equity - Pharmaceuticals & Health Care
over : 30/04/2015 - 30/04/2018

Total Return

Month by Month Performance

Quarterly Performance

to 31/03/2018 Annual Q1 Q2 Q3 Q4
2018 -0.1%
2017 20.7% 11.1% 6.7% 1.3% 0.5%
2016 -8.8% -9.1% 5.2% 2.0% -6.5%
2015 4.0% 8.1% 3.6% -9.6% 2.6%
2014 25.6% 14.8% 1.2% 1.2% 6.9%
2013 13.6% 11.6%

Related News

Polar Capital launches absolute return UK equities fund

London-based asset management firm unveils long/short equity strategy for recent recruit.

Polar Capital hires ex-Threadneedle star for income push

Citywire + rated manager taken on to spearhead London-based investment firm's efforts to build a European equity income franchise.

Citywire Discovery Source: Citywire Discovery Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated)..Portions of the information contained on this page was derived by Citywire Financial Publishers Ltd using content supplied by Lipper, A Reuters Company.